Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 7 | 2020 | 318 | 1.830 |
Why?
|
| Polymers | 3 | 2020 | 121 | 1.240 |
Why?
|
| Paclitaxel | 2 | 2020 | 50 | 1.170 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2020 | 110 | 1.070 |
Why?
|
| Polyesters | 2 | 2014 | 25 | 0.940 |
Why?
|
| Drug Delivery Systems | 6 | 2019 | 202 | 0.890 |
Why?
|
| Naltrexone | 3 | 2011 | 38 | 0.760 |
Why?
|
| Computer-Aided Design | 2 | 2020 | 11 | 0.720 |
Why?
|
| Lactams, Macrocyclic | 1 | 2020 | 8 | 0.720 |
Why?
|
| Narcotic Antagonists | 2 | 2011 | 57 | 0.710 |
Why?
|
| Benzoquinones | 1 | 2020 | 36 | 0.700 |
Why?
|
| Technology, Pharmaceutical | 2 | 2015 | 27 | 0.650 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 227 | 0.630 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 51 | 0.630 |
Why?
|
| Drug Carriers | 2 | 2017 | 125 | 0.620 |
Why?
|
| Delayed-Action Preparations | 2 | 2014 | 60 | 0.570 |
Why?
|
| Chemistry, Pharmaceutical | 4 | 2017 | 71 | 0.550 |
Why?
|
| Particle Size | 4 | 2020 | 215 | 0.540 |
Why?
|
| Drug Industry | 1 | 2015 | 14 | 0.540 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 803 | 0.470 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 409 | 0.450 |
Why?
|
| Surface Properties | 3 | 2020 | 130 | 0.420 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 420 | 0.390 |
Why?
|
| Microspheres | 1 | 2011 | 49 | 0.380 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1502 | 0.360 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2020 | 364 | 0.300 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 519 | 0.230 |
Why?
|
| Hydrogels | 1 | 2003 | 37 | 0.220 |
Why?
|
| Trophoblasts | 1 | 2022 | 24 | 0.210 |
Why?
|
| HIV Infections | 1 | 2015 | 2303 | 0.200 |
Why?
|
| Education, Pharmacy | 1 | 2021 | 43 | 0.180 |
Why?
|
| Capsules | 1 | 2020 | 25 | 0.180 |
Why?
|
| Students, Pharmacy | 1 | 2021 | 47 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 13 | 0.170 |
Why?
|
| Drug Resistance | 1 | 2019 | 99 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 128 | 0.150 |
Why?
|
| Acetals | 1 | 2017 | 2 | 0.150 |
Why?
|
| Benzaldehydes | 1 | 2017 | 7 | 0.150 |
Why?
|
| Micelles | 1 | 2017 | 32 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2017 | 99 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 409 | 0.130 |
Why?
|
| Time Factors | 2 | 2011 | 1742 | 0.130 |
Why?
|
| Molecular Structure | 1 | 2017 | 492 | 0.130 |
Why?
|
| Humans | 6 | 2022 | 37093 | 0.130 |
Why?
|
| RNA Interference | 1 | 2015 | 243 | 0.120 |
Why?
|
| Quality of Life | 1 | 2019 | 481 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2015 | 153 | 0.120 |
Why?
|
| Ovary | 1 | 2014 | 108 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 142 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2014 | 337 | 0.110 |
Why?
|
| Breast | 1 | 2014 | 135 | 0.110 |
Why?
|
| Animals | 3 | 2015 | 15081 | 0.100 |
Why?
|
| Transition Temperature | 1 | 2011 | 8 | 0.100 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 50 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2011 | 37 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2011 | 167 | 0.100 |
Why?
|
| Solubility | 1 | 2011 | 118 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 312 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2011 | 95 | 0.090 |
Why?
|
| Temperature | 1 | 2011 | 286 | 0.090 |
Why?
|
| Female | 3 | 2022 | 20969 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 62 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2008 | 233 | 0.080 |
Why?
|
| Alcoholism | 1 | 2011 | 240 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2231 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 421 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2008 | 314 | 0.070 |
Why?
|
| Methacrylates | 1 | 2003 | 5 | 0.060 |
Why?
|
| Azo Compounds | 1 | 2003 | 20 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 58 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 431 | 0.050 |
Why?
|
| Placenta | 1 | 2022 | 97 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 107 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 196 | 0.050 |
Why?
|
| Rats | 1 | 2008 | 3483 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2021 | 86 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2022 | 517 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 442 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 1549 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2026 | 0.030 |
Why?
|
| Male | 1 | 2008 | 20025 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2002 | 68 | 0.010 |
Why?
|